Skip to main content

People in the News: Kjell Kristiansen, Paul Billings

Premium

Microtest Diagnostics has named Kjell Kristiansen as group managing director.

Kristiansen joins Microtest from Phadia, where he was regional director for Asia for 14 years. Thermo Fisher acquired Phadia last year.

London-based Microtest said it made the appointment as it prepares to launch its microarray-based ADAM in vitro allergy and autoimmunity testing platform.


Ancestry.com has appointed Paul Billings to its board of directors. Billings has also been named a member of the company's audit committee.

Billings is currently chief medical officer at Life Technologies. He also was CEO of Cellective Dx and senior vice president of Laboratory Corporation of America.

Ancestry.com CEO Tim Sullivan called Billings a "great addition" to its board when its "focus on genetic genealogy is just beginning." Ancestry.com last month introduced a testing service called AncestryDNA that relies on the Illumina BeadChip platform (BAN 5/29/2012).

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.